Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer - Wikidata - wikimedia - TriplyDB

Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer

Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer

http://www.wikidata.org/entity/Q28343446

about

Erythropoietin or darbepoetin for patients with cancer Drug therapy for the management of cancer-related fatigue Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data Drug therapy for the management of cancer related fatigue Erythropoietin for patients with malignant disease Erythropoietin or Darbepoetin for patients with cancer Erythropoietin, uncertainty principle and cancer related anaemia.Estimating the mean and variance from the median, range, and the size of a sample Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes.Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials.Pharmacotherapy of anaemia in cancer patients.Standards of care for anemia management in oncology: focus on lung carcinoma.Overview of cancer-related anemia: focus on the potential role of darbepoetin alfa.Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy.Safety considerations for erythropoietin treatment in patients with cancer.Pleiotrophic actions of erythropoietin Emerging technologies in the delivery of erythropoietin for therapeutics.Venous thromboembolism risk and erythropoiesis-stimulating agents for the treatment of cancer-associated anemia: a meta-analysis.Role of hematopoietic growth factors as adjuncts in the treatment of chronic hepatitis C patients.Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy--results of a randomized trial.

P2860

Q24202335-5ACCF3D6-5A9C-405B-B83B-8D928EC8FBE2 Q24234267-C545FB0E-5F80-487F-848D-E07720D90E94 Q24240202-0AC4F06D-A79E-4D59-B73E-DD0339544AE5 Q24242050-1804B190-8703-46D5-9A02-957B7024E4F0 Q24245427-0C7B1483-96F1-45D0-B6FA-D1A92FA16C10 Q24245464-3A682C6A-A688-48A9-BEF6-5CEC978A96DA Q24791480-C28AD14B-5BDA-409D-90C5-1F18C7A3F635 Q24801782-C6AF77BF-CC89-4F31-B43D-2F1848FC6241 Q30803363-F578F9D2-C31B-4A66-9572-91D6EE026303 Q33243661-37536A2C-6743-47E3-B1A5-3AF4A7B54204 Q33344979-9C2BE2B3-50F9-483B-A2F6-A46482D1B7F3 Q33630871-B05E97FF-0B09-4980-BF93-4768BDF4405A Q34337012-EB4E248B-C240-4178-A7BC-389F679DA00F Q34515556-DC19E42F-7AA9-4475-A3A2-E69107156F06 Q34810857-7BEA596C-0DA5-45C7-A453-91FB76DB97CA Q34834866-F4BC55E1-F39C-4412-B349-80B949FFA086 Q35696941-9B9A8B1B-C1F2-49AF-A747-35C743A8B57F Q36689075-CBB33D14-8413-41DF-A7AC-00949263B784 Q37296277-A09DB7E3-4764-490F-937E-AD04CFB6DE08 Q37646523-34386571-98CD-490E-A647-171647A2DD1A Q38130141-8416387C-D900-4807-8006-373B8DEA2EA5 Q41860936-6907D61B-657A-4F15-B66B-1E7D85937950 Q44544276-876F6E47-A7B6-41FE-9DB8-8751AD9319C8

P2860

Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer

http://www.wikidata.org/entity/Q28343446

description

1999 nî lūn-bûn

@nan

1999 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Epoetin alpha prevents anaemia ...... apy for small cell lung cancer

@ast

Epoetin alpha prevents anaemia ...... apy for small cell lung cancer

@en

Epoetin alpha prevents anaemia ...... apy for small cell lung cancer

@nl

type

label

Epoetin alpha prevents anaemia ...... apy for small cell lung cancer

@ast

Epoetin alpha prevents anaemia ...... apy for small cell lung cancer

@en

Epoetin alpha prevents anaemia ...... apy for small cell lung cancer

@nl

prefLabel

Epoetin alpha prevents anaemia ...... apy for small cell lung cancer

@ast

Epoetin alpha prevents anaemia ...... apy for small cell lung cancer

@en

Epoetin alpha prevents anaemia ...... apy for small cell lung cancer

@nl

P1433

Q28343446-56519A00-8D61-4817-AED8-1A2E01E8BF1F

P1476

Q28343446-5E6E22EE-E6A1-4ABF-8F5D-F9F5F0A43113

P2093

Q28343446-1EB85856-A832-4241-A415-980B23D0C37F

Q28343446-242524CE-0A2A-4F73-852F-9758D17181B8

Q28343446-365E0C00-B6E3-49D8-89C7-F929F774DB45

Q28343446-3FC7A32A-AC83-4BA7-AC8E-D2074E800526

Q28343446-68BFA9ED-4164-4AD6-85C1-0F90FF29F9A7

Q28343446-73546D2A-3D85-4C0D-99F2-B0EEBF34B833

Q28343446-8071E577-06AA-41BB-878B-321B51CD5DFE

Q28343446-82A373C4-CEC0-4DFE-83EE-F83C27DBFBFD

Q28343446-AE3AC999-264E-4AF2-86C3-1047D9200261

Q28343446-AFA092CD-7416-43C3-ADAB-4560B2CE0487

P2860

Q28343446-0476C56C-C45B-49AE-8003-C99F7DCFAC65

Q28343446-1CE13E9D-AB5D-4A16-B3F9-56582594FE58

Q28343446-32BCCFFA-E8A6-47B8-AEE1-D25131E33BAF

Q28343446-62268E52-3E1F-4995-B990-4998ED9D3F8D

Q28343446-677DF119-0740-446C-8087-9F14FBAB6F85

Q28343446-7ABBDB46-AF85-4B97-B099-72F6E8478D0B

Q28343446-993EE63B-A1F4-4606-A537-FED064AA2594

Q28343446-A1C689D3-0075-4627-83CB-21113FDD9366

Q28343446-DB4B0420-0BAD-4177-801D-6492365913A6

P2888

Q28343446-E0CB7402-25E4-4AD2-9496-B86B3D785BD7

P304

Q28343446-5CD7B8CA-3E5E-47B1-B73B-1C96080F86DF

P31

Q28343446-4E387EEC-3311-477E-9982-01CDEDC7F9E8

P356

Q28343446-CD5D4A42-3126-4B2F-8FF8-F938B0426737

P407

Q28343446-4C1E5609-8B3C-4D77-8007-BFE30718E56F

P433

Q28343446-30BC47CE-C468-4CF7-BE99-D81AE024BF5B

P478

Q28343446-467AE91B-1426-412C-B003-D2708041CFBB

P577

Q28343446-819D8EA1-AA82-45D7-B6EB-1F7692A2AC2F

P5875

Q28343446-385D8B75-8819-451F-B13D-D09B0B5C50F0

P6179

Q28343446-2592B183-C55B-4DD8-8DAF-0C4F03482ED5

P698

Q28343446-64555DD3-E80B-40F2-AF12-1EC4DCC049CC

P921

Q28343446-9A99AC77-D2EF-408F-8BDD-4F62A15AF833

P932

Q28343446-A0155433-8356-4A17-BA42-B71F546F6424

P356

P1433

British Journal of Cancer

P1476

Epoetin alpha prevents anaemia ...... apy for small cell lung cancer

@en

P2093

D R Bell

http://www.w3.org/2001/XMLSchema#string

E S De Campos

http://www.w3.org/2001/XMLSchema#string

E Schatzmann

http://www.w3.org/2001/XMLSchema#string

E Sundal

http://www.w3.org/2001/XMLSchema#string

G Varghese

http://www.w3.org/2001/XMLSchema#string

H Stocker

http://www.w3.org/2001/XMLSchema#string

J F Vansteenkiste

http://www.w3.org/2001/XMLSchema#string

N Thatcher

http://www.w3.org/2001/XMLSchema#string

R Morant

http://www.w3.org/2001/XMLSchema#string

R Rosso

http://www.w3.org/2001/XMLSchema#string

P2860

Reporting results of cancer treatment

Carboplatin: the clinical spectrum to date.

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.

Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study

Effects of transfusion on immune function. Cancer recurrence and infection.

Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinoma.

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.

Erythropoietin treatment of anemia associated with multiple myeloma.

Effect of cis-diamminedichloroplatinum on erythropoietin production and hematopoietic progenitor cells.

P2888

P304

396-402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6690369

http://www.w3.org/2001/XMLSchema#string

P407

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P577

1999-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12890293

http://www.w3.org/2001/XMLSchema#string

P6179

1013590128

http://www.w3.org/2001/XMLSchema#string

P698

10408844

http://www.w3.org/2001/XMLSchema#string

P921

P932

2362337

http://www.w3.org/2001/XMLSchema#string